Original articleQuantitative Fundus Autofluorescence Distinguishes ABCA4-Associated and Non–ABCA4-Associated Bull's-Eye Maculopathy
Section snippets
Patients and Genetic Testing
Thirty-seven BEM patients (age range, 8–60 years) from 35 families were recruited prospectively at the Department of Ophthalmology, Columbia University. All subjects were examined by a retinal specialist (S.H.T.) and had clear media except for some floaters. Patients exhibiting the BEM phenotype were selected on the basis of fundus AF images. All patients exhibited a localized macular lesion exhibiting a smooth contour; outside the macula, the retina was qualitatively normal and without flecks.
Results
ABCA4 mutations were identified in 22 patients, including 21 patients (95%) with both disease-causing ABCA4 variants (Table 1). One patient was homozygous and 13 patients were compound heterozygous for the p.G1961E variant. ABCA4 was excluded as the causal gene in 15 patients because no mutations were detected after complete sequencing of the ABCA4 exons and adjacent intronic sequences. ABCA4-positive patients tended to be younger (mean age, 21.9±8.3 years) than ABCA4-negative patients (mean
Discussion
In this study, we assessed whether qAF, an indirect measure of RPE lipofuscin, could aid in differentiating ABCA4-positve from ABCA4-negative cases of BEM. Quantitative AF clearly distinguished the 2 groups. Specifically, qAF analysis indicated that ABCA4-positive BEM patients have increased lipofuscin levels throughout the posterior pole, whereas patients with BEM resulting from mutations in other genes have qAF levels within normal limits for age. These data reinforce the clinical usefulness
References (39)
- et al.
G1961E mutant allele in the Stargardt disease gene ABCA4 causes bull's eye maculopathy
Exp Eye Res
(2009) - et al.
Mutation in the gene GUCA1A, encoding guanylate cyclase-activating protein 1, causes cone, cone-rod, and macular dystrophy
Ophthalmology
(2005) - et al.
The bisretinoids of retinal pigment epithelium
Prog Retin Eye Res
(2012) - et al.
Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus
Ophthalmology
(1994) - et al.
Retinal pigment epithelial abnormalities in fundus flavimaculatus: a light and electron microscopic study
Ophthalmology
(1980) - et al.
The clinical effect of homozygous ABCA4 alleles in 18 patients
Ophthalmology
(2013) - et al.
A Drosophila genetic resource of mutants to study mechanisms underlying human genetic diseases
Cell
(2014) - et al.
Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine
Invest Ophthalmol Vis Sci
(2006) - et al.
Clinical variations in assessment of bull's-eye maculopathy
Arch Ophthalmol
(2002) - et al.
ABCA4 mutations and discordant ABCA4 alleles in patients and siblings with bull's-eye maculopathy
Br J Ophthalmol
(2007)
Chloroquine retinopathy. Evaluation by fluorescein fundus angiography
Arch Ophthalmol
The PROM1 mutation p.R373C causes an autosomal dominant bull's eye maculopathy associated with rod, rod-cone, and macular dystrophy
Invest Ophthalmol Vis Sci
A detailed study of the phenotype of an autosomal dominant cone-rod dystrophy (CORD7) associated with mutation in the gene for RIM1
Br J Ophthalmol
An autosomal dominant bull's-eye macular dystrophy (MCDR2) that maps to the short arm of chromosome 4
Invest Ophthalmol Vis Sci
Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and update
Doc Ophthalmol
Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy
Br J Ophthalmol
In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics
Invest Ophthalmol Vis Sci
Quantitative fundus autofluorescence in healthy eyes
Invest Ophthalmol Vis Sci
Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects
Invest Ophthalmol Vis Sci
Cited by (70)
A high fat diet fosters elevated bisretinoids
2023, Journal of Biological ChemistryProgression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 24-Month Period (ProgStar Report No. 17)
2023, American Journal of OphthalmologyOphthalmic phenotyping: Imaging
2022, Clinical Ophthalmic Genetics and GenomicsFundus autofluorescence imaging
2021, Progress in Retinal and Eye ResearchCitation Excerpt :A normal FAF signal, therefore, does not necessarily reflect an intact photoreceptor–RPE complex, but may rather correspond to a structurally intact-appearing RPE cell monolayer with or without the presence of intact photoreceptors. QAF imaging has been shown to be useful for differential diagnosis in retinal dystrophies, e.g., qAF allows for differentiation between ABCA4-associated and non-ABCA4-associated retinal disease (Duncker et al., 2015c). Moreover, PRPH2/RDS- and ABCA4-associated disease exhibiting phenotypic overlap may be partially discriminated when qAF values are corrected for age and race.
Quantitative Fundus Autofluorescence in ABCA4-Related Retinopathy -Functional Relevance and Genotype-Phenotype Correlation
2021, American Journal of OphthalmologyBisretinoid phospholipid and vitamin a aldehyde: Shining a light
2021, Journal of Lipid ResearchCitation Excerpt :Also complicating this issue is the possibility of greater photocleavage and loss of bisretinoid in central cone-rich retina due to higher light exposures (96). Thus, the question of cone versus rod bisretinoid formation cannot be addressed by noninvasive quantitative fundus autofluorescence imaging (97) in human subjects. Nevertheless, some insight was provided by studies of mice deficient in the Nrl transcription factor (Nrl−/−) (98).
Supplemental material is available at www.aaojournal.org.
Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Supported in part by the National Eye Institute, National Institutes of Health, Bethesda, Maryland (grant nos. EY024091, EY021163, EY019861, and P30EY019007); Foundation Fighting Blindness (Owings Mills, MD; grant no. C-CL-0710); and a grant from Research to Prevent Blindness, New York, New York, to the Department of Ophthalmology, Columbia University. During initial stages of the work, Dr. Delori was supported partially by the National Eye Institute (grant no. EY015520).